Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

| More on:
Six smiling health workers pose for a selfie.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sigma Healthcare Ltd (ASX: SIG) shares have been on a tear this past year.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock – which owns chemists including Amcal, Discount Drug Stores, and Guardian Pharmacy – really took off a bit over a year ago, in December 2023.

That's when Sigma first announced its $30 billion merger intentions with privately owned Chemist Warehouse.

As those merger plans progressed throughout 2024 and into 2025, Sigma shares made some ASX investors very happy.

How happy?

Let's have a look.

What $5,000 invested in Sigma shares last December is worth today

If you had a working time machine, you could pop back to 1 December 2023 and snap up Sigma shares for 69 cents apiece.

This means your $5,000 investment would have netted you 7,246 shares (ignoring brokerage fees).

In late afternoon trade today, those same shares are changing hands for $2.75 apiece.

That means the Sigma shares you bought on 1 December 2023 for $5,000, less than 15 months ago mind you, is now worth a whopping $19,926.50. Or a gain of 298.6%.

But we're not quite done with the maths yet.

Adding a little icing to this highly profitable cake, you'd also have received a total of 1 cent per share in partly franked dividends over this period.

Which would bring your total returns on the initial $5,000 investment to $19,998.96.

Now, when you're done with the time machine, can you please drop it by my office!

What's the latest on the pending merger with Chemist Warehouse?

On 30 January, ASX 200 investors learned that, as expected, Sigma shareholders had voted to approve the merger with Chemist Warehouse, with 99.86% voting 'yes'.

Sigma shareholders also agreed to elect four Chemist Warehouse executives to the Sigma board.

The Chemist Warehouse board's vote to approve the merger received 99.23% support.

Commenting on the merger on the day, Sigma chair Michael Sammells said:

Sigma has world-class distribution infrastructure and capability that is delivering best in class service to pharmacies across Australia every day.

Chemist Warehouse has unparalleled pharmacy franchise and marketing know-how and expertise which will also help elevate our support for our Amcal and Discount Drug Store franchisees.

Given the nature and value accretion of the proposed transaction, Sigma Directors unanimously recommend that shareholders vote in favour of the resolutions.

Sigma shares had been in a trading halt the day before and closed down 3.6% following the news.

Though, as we saw above, that hardly crimped the returns investors have reaped since the merger news first broke in December 2023.

The merger process was finalised this afternoon when Sigma announced that its 100% acquisition of issued shares in Chemist Warehouse via a scheme of arrangement was implemented today.

Should you invest $1,000 in Sigma Healthcare right now?

Before you buy Sigma Healthcare shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma Healthcare wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX All Ords stock is up 10% on big news

This high-flying stock just can't stop rising. What's going on?

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

Telix shares rocket 15% on stellar Q1 sales update

Let's see how the company performed during the three months.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

Macquarie's top 3 ASX stock picks in the healthcare sector

Top broker has revealed 3 healthcare stocks with upside. 

Read more »

Two lab workers fist pump each other.
Healthcare Shares

3 of the best ASX 200 healthcare shares to bring your portfolio to life

These shares could be just what the investment doctor ordered according to analysts.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Share Gainers

Guess which ASX All Ords stock just rocketed 28% on a new commercial contract!

The ASX All Ords stock has grabbed plenty of investor interest on Tuesday.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Is the CSL share price a buy? Here's a top broker's view

Is this stock a healthy opportunity? Let’s have a look.

Read more »

Man ecstatic after reading good news.
Healthcare Shares

Which ASX company has just secured FDA approval?

This stock just announced some big news.

Read more »

Health professional putting on gloves.
Healthcare Shares

How will Ansell shares navigate tariffs according to Macquarie?

The next two years could be a challenging period for the PPE company.

Read more »